Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NmCV-5 in Healthy Malian Children
NCT03295318Phase 2Completed
- Sponsor
- Serum Institute of India
- Start
- Nov 2017
- Primary completion
- Aug 2018
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of NmCV-5 in meningococcal meningitis, sponsored by Serum Institute of India. Started Nov 2017; status: completed.
02
Drugs
NmCV-5
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT03295318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03295318.